BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 19295320)

  • 1. Successful tapering of immunosuppression to low-dose monotherapy steroids after living-related human leukocyte antigen-identical renal transplantation.
    van de Wetering J; Gerrits JH; van Besouw NM; Ijzermans JN; Weimar W
    Transplantation; 2009 Mar; 87(5):740-4. PubMed ID: 19295320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches.
    Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM
    Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective trial of a steroid-free/calcineurin inhibitor minimization regimen in human leukocyte antigen (HLA)-identical live donor renal transplantation.
    Walker JK; Alloway RR; Roy-Chaudhury P; Mogilishetty G; Cardi MA; Weimert NA; Rike AH; First MR; Woodle ES
    Transplantation; 2009 Feb; 87(3):408-14. PubMed ID: 19202447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients.
    Gerrits JH; van de Wetering J; Weimar W; van Besouw NM
    Transplantation; 2009 Mar; 87(6):907-14. PubMed ID: 19300195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of living kidney transplantation from HLA-identical sibling donors under calcineurin inhibitor immunosuppression.
    Shimmura H; Tanabe K; Ishida H; Miyamoto N; Tokumoto T; Ishikawa N; Toma H
    Int J Urol; 2006 May; 13(5):502-8. PubMed ID: 16771716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
    Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
    Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year results of renal transplantation using only azathioprine and low-dose prednisolone as immunosuppression.
    McGeown MG; Doherty CC; Douglas JF; Donaldson RA; Hill CM; Kennedy JA; Loughridge WG; Middletown D
    Clin Transpl; 1989; ():191-9. PubMed ID: 2487566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Sobh M; Ghoneim M
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bergamo Kidney Transplant Program.
    Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
    Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiplex bead array analysis to monitor donor-specific cytokine responses after withdrawal of immunosuppression in HLA-identical living related kidney transplant patients.
    Gerrits JH; van de Wetering J; van Beelen E; Claas FH; Weimar W; van Besouw NM
    Transplant Proc; 2009 Jun; 41(5):1577-82. PubMed ID: 19545683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients.
    Cueto-Manzano AM; Konel S; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
    Transplantation; 2003 Jun; 75(12):2053-8. PubMed ID: 12829911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steroid withdrawal in renal transplant recipients].
    Nakamura H; Murai M; Asano T; Takao M; Yoshizawa N; Sekiguchi S
    Nihon Jinzo Gakkai Shi; 1990 Sep; 32(9):1033-7. PubMed ID: 2263025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cessation of steroids in stable renal transplant patients: the Leuven experience.
    Maes BD; Claes K; Coosemans W; Evenpoel P; Kuypers D; Pirenne J; Vanrenterghem Y
    Clin Transpl; 2002; ():181-9. PubMed ID: 12971448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful steroid withdrawal after long-term administration in renal transplant patients.
    Amada N; Kikuchi H; Haga I; Fukumori T; Sato A; Sato T
    Transplant Proc; 2009; 41(1):135-7. PubMed ID: 19249498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
    Thielke JJ; West-Thielke PM; Herren HL; Bareato U; Ommert T; Vidanovic V; Campbell-Lee SA; Tzvetanov IG; Sankary HN; Kaplan B; Benedetti E; Oberholzer J
    Transplantation; 2009 Jan; 87(2):268-73. PubMed ID: 19155983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-reactive cytokine profiles after HLA-identical living-related kidney transplantation.
    Gerrits JH; van de Wetering J; Drabbels JJ; Claas FH; Weimar W; van Besouw NM
    Nephrol Dial Transplant; 2008 Jun; 23(6):2016-23. PubMed ID: 18156655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.